> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# AdvaMed Bill Addresses Some FDA Shutdown Issues
- URL: https://www.fdaweb.com/advamed-bill-addresses-some-fda-shutdown-issues/
- Published: 2019-01-24T12:00:00.000Z
- Updated: 2026-09-15T00:56:46.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5143222

AdvaMed says it is proposing legislation to help “fix” some of the disruption FDA is experiencing in collecting user fees and reviewing medical device applications during this and any future government shutdowns. Under the proposal, the trade group [says](https://www.medtechintelligence.com/news%5Farticle/advameds-legislative-proposal-seeks-to-ease-issues-related-to-user-fees-and-device-submissions-during-shutdown/?ref=fdaweb.com), FDA could continue to collect user fees and review applications that come in with the user fees during a shutdown.

AdvaMed president **Scott Whitaker** said the group is concerned about the shutdown’s long-term impact on the device approval process since carryover balances are only expected to last two to three months. With an average number of device submissions to FDA reaching upwards of 300 per month, he said, a prolonged shutdown means a significant backlog.